Skip to main content

Month: March 2022

Customer Experience Management Market to Reach USD 32.53 Billion by 2029; Growing Adoption of Artificial Intelligence and Augmented Reality to Propel Market Growth

Companies Profiled Global Customer Experience Management Market: Zendesk Inc. (San Francisco, U.S.), SAP SE (Walldorf, Germany), Oracle Corporation (Texas, U.S.), Adobe Inc. (California, U.S.), Medallia Inc. (California, U.S.), OpenText Corporation (Waterloo, Canada), Microsoft Corporation (Washington, U.S.), Salesforce.com, Inc. (California, U.S.), Genesys (California, U.S.), Freshworks Inc. (California, U.S.) Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — The global customer experience management market size is predicted to be worth USD 32.53 billion by 2029 and exhibit a CAGR of 16.2% during the forecast period. Customer experience management solutions help enterprises to reduce their customer churn rates and improve their customer loyalty. They also help business to increase their brand presence. The growing digitization and...

Continue reading

Auriant Mining AB (publ.) comments on the Group’s operations

In the past few days following the outbreak of the Russian military operation in Ukraine, our thoughts are with those who have been directly affected by the situation.    The Company wishes to provide the following update on the Group’s operations: •   Mining operations and gold production at the Tardan CIL plant continue as usual without interruptions;•   There have been no interruptions in supplies, although the Company’s subsidiaries  operating in Russia are seeing price increases;•   The Group sold all its gold stock produced before the end of February and gold sales are continuing.  All gold sales are executed in Russia;•   In view of the sanctions imposed on the Company’s bank VTB by the US, the EU, and the UK, the Group is reviewing its gold sales processes, and is considering alternative sales channels; •   The Company is working...

Continue reading

Scatec partners with the SCZONE, The Sovereign Fund of Egypt, the Ministry of Electricity and Renewable Energy to develop a large-scale green ammonia facility in Egypt

Oslo, 10 March 2022: Scatec has today signed a memorandum of understanding (MOU) with the General Authority for Suez Canal Economic Zone (SCZONE), The Sovereign Fund of Egypt (TSFE), the Egyptian Electricity Transmission Company (EETC), and the New and Renewable Energy Authority (NREA), to jointly develop a green ammonia facility in Egypt with a production capacity of one million tonnes annually and with a potential for an expansion to three million tonnes annually. The green hydrogen and ammonia facility will be located in the SCZONE in Ain Sokhna Industrial Zone and will be powered by renewable energy plants to be built in close proximity on an area of land allocated by NREA. This is the first large-scale project for production of green ammonia in the country, which also includes the participation of the Government of Egypt and is a...

Continue reading

The Social Insurance Institution of Finland selects Innofactor as the provider of an administrative case management solution

Innofactor Plc Inside Information, on March 10, 2022, at 9:45 Finnish time  The Social Insurance Institution of Finland (Kela) has selected Innofactor in a public procurement competition as the provider of an administrative case management solution. The procurement includes the case management solution based on Innofactor’s Dynasty 10 system, delivery project, maintenance and support services, and separately ordered expert services. The total value (excluding VAT) stated by The Social Insurance Institution of Finland in the procurement decision is approximately EUR 0.7 million. The agreement will be valid for a fixed period of four years, after which it will be valid until further notice. The Social Insurance Institution of Finland (Kela) is an independent social security institution monitored by the Parliament. It provides social security...

Continue reading

Mkango Issues Shares to Bacchus Capital in Relation to Its Previously Announced Engagement as Strategic and Financial Advisor

LONDON and VANCOUVER, British Columbia, March 10, 2022 (GLOBE NEWSWIRE) — Mkango Resources Ltd. (AIM/TSX-V: MKA) (the “Company” or “Mkango”) announces that, further to its press releases of December 21, 2020 and February 8, 2021, it has issued 625,000 shares (the “Shares”) to Bacchus Capital Advisors Limited (“Bacchus Capital”), in connection with the financial advisory services provided by Bacchus Capital to the Company for the period from December 18, 2020 to December 18, 2021.  The Shares were issued at a deemed price per Share of C$0.475.  The Shares may not be sold through the facilities of the TSX-V or, absent a prospectus exemption, otherwise to a resident of Canada until 4 July, 2022, being the date which is 4 months plus one day from issuance.  Final acceptance of the TSX Venture Exchange (“TSX-V”)...

Continue reading

Aspocomp’s Financial Statement Release January 1-December 31, 2021: A strong fourth quarter ensured clear growth and improved operating profit for the full year

Aspocomp Group Plc, Financial Report, March 10, 2022 at 9:00 a.m. EET Key figures 10-12/2021 in brief  10-12/2021 10-12/2020   Change *Net sales 10.8 M€ 5.9 M€   81 %EBITDA 1.7 M€ 0.4 M€   334 %Operating result 1.2 M€ 0.0 M€   2829 %   % of net sales 11.5 % -0.8 %   12 pptsEarnings per share 0.17 € 0.02 €   750 %Operative cash flow 1.8 M€ 0.2 M€   717 %Equity ratio 60.8 % 63.6 %   -3 pptsKey figures 1-12/2021 in brief  1-12/2021 1-12/2020   Change *Net sales 33.2 M€ 25.6 M€   29 %EBITDA 4.1 M€ 1.5 M€   168 %Operating result 2.2 M€ -0.1 M€   1808 %   % of net sales 6.8 % -0.5 %   7 pptsEarnings per share...

Continue reading

ObsEva Announces Year End 2021 Financial Results and Provides Corporate Update

-Linzagolix for uterine fibroids: US NDA Q3:22 PDUFA date; Positive CHMP opinion- -Linzagolix for endometriosis: Reported positive topline results for linzagolix 200 mg with add-back therapy in the Phase 3 EDELWEISS 3 trial- -Linzagolix franchise: Entered strategic licensing agreement with Theramex for commercialization across global markets outside of the U.S., Canada, and Asia- -Linzagolix franchise: Entered into commercial sales agreement with Syneos Health to commercialize within the United States- Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange                 GENEVA, March 10, 2022 (GLOBE NEWSWIRE) — ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today reported financial results for the full year...

Continue reading

Net asset value of EfTEN Real Estate Fund III AS as of 28.02.2022

The net asset value (NAV) of EfTEN Real Estate Fund III AS was 19.3997 euros as of 28.02.2022, increasing by 0.8% during February. The net asset value of the EPRA share (EPRA NRV – net book value excluding the deferred income tax liability and the fair value of interest rate derivatives) was 20.56 euros as of 28.02.2022. EPRA NAV also increased by 0.8% in February. In February, the fund earned a total of 1,101 thousand euros in consolidated rental income, which is 14 thousand euros more than in January. The Fund’s consolidated EBITDA in February was 986 thousand euros (37 thousand euros more than in January). During the first two months of 2022, the fund has earned a total of 2,188 thousand euros in rental income and 1,936 thousand euros in EBITDA, including EBITDA on a comparable basis for investment properties that were on...

Continue reading

Correction: Central Bank of Savings Banks Finland Plc – Board of Directors’ report and financial statements 31 December 2021 in xHTML-format

Central Bank of Savings Banks Finland PlcStock Exchange Release  10th of March 2022 at 8 am (CET +1)  Central Bank of Savings Banks Finland Plc has published corrected Board of Directors’ report and financial statements 31 December 2021 in xHTML-format according to ESEF reporting requirement. Material is available in Finnish at www.saastopankki.fi. Further information:  Kai Brander, Managing Director   Central Bank of Savings Banks Finland Plc kai.brander@saastopankki.fi +358 50 384 8220  Central Bank of Savings Banks Finland Plc is part of the Savings Banks Amalgamation and Savings Banks Group and operates as Group’s central credit institution. Central Bank of Savings Banks’ role is to ensure liquidity and wholesale funding of the Savings Banks Group via operating in the money and capital markets, issue payment cards, and...

Continue reading

Boskalis annual results 2021: Strong increase in revenue and result

Papendrecht, 10 March 2022 KEY FIGURES 2021Revenue: EUR 2.96 billion(2020: EUR 2.52 billion)EBITDA: EUR 462 million(2020: EUR 404 million)Net profit: EUR 151 million(2020: loss EUR 97 million)Order book: EUR 5.41 billion(2020: EUR 5.31 billion)Dividend proposal: EUR 0.50 per share all cashOUTLOOKWell-filled order book offers solid basis for 2022 Dredging: steady pick-up of market volume with stable margins Offshore Energy: stable strong market outlook for 2022 Announcing EUR 100 million share buyback program Favorable short and medium term outlook; full impact of recent geopolitical developments still difficult to assessRoyal Boskalis Westminster N.V. (Boskalis) concluded 2021 with a strong increase in revenue and earnings and with a well-filled order book, despite COVID-19-related restrictions. Revenue increased...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.